“More food stamps? Or more paychecks?” Former Speaker of the House Newt Gingrich suggests that’s how the GOP should couch the national policy debate before the midterm elections. But will demonizing programs that aid the poor h…
The financial media loves to pluck struggling analysts from obscurity and propel them to fame on the backs of a few good calls, then shoot them full of arrows at them when their predictions start to fail. And inevitably, those …
The state’s House Democratic delegation has asked the Justice Department, the Fed and Controller of the Currency to investigate the widespread — and growing — problem of faulty bank documents in foreclosure cases. One agency …
CNBC’s Larry Kudlow blogged Tuesday that the a GOP win in November’s elections would create an explosion of U.S. job creation. One of his guests that day on The Kudlow Report was DailyFinance’s Peter Cohan, who breaks down prec…
Dendreon’s Provenge, which targets prostate cancer, catapulted that company’s stock to record highs recently. Prima Biomed’s CVac works similarly, but it has the potential to target multiple forms of cancer, giving the company …